Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology-Reference-Cited by-同舟云学术

Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology

Published:2017-11-01 Issue:1 Volume:71 Page:60-71
ISSN:0021-8820
Container-title:The Journal of Antibiotics
language:en
Short-container-title:J Antibiot

Author:

Adachi Hayamitsu,Nakae Koichi,Sakamoto Shuichi,Nosaka Chisato,Atsumi Sonoko,Shibuya Masabumi,Higashi Nobuaki,Nakajima Motowo,Irimura Tatsuro,Nishimura Yoshio

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology

Link

http://www.nature.com/articles/ja2017138.pdf

Reference86 articles.

1. Aoyagi, T. [An outline of enzyme inhibitors]. Tanpakushitsu Kakusan Koso 38, 1891–1918 (1993).

2. Aoyagi, T., Takeuchi, T., Matsuzaki, A., Kawamura, K. & Kondo, S. Leupeptins, new protease inhibitors from Actinomycetes. J. Antibiot. (Tokyo) 22, 283–286 (1969).

3. Umezawa, H., Aoyagi, T., Morishima, H., Kunimoto, S. & Matsuzaki, M. Chymostatin, a new chymotrypsin inhibitor produced by actinomycetes. J. Antibiot. (Tokyo) 23, 425–427 (1970).

4. Aoyagi, T. et al. Poststatin, a new inhibitor of prolyl endopeptidase, produced by Streptomyces viridochromogenes MH534-30F3. I. Taxonomy, production, isolation, physico-chemical properties and biological activities. J. Antibiot. (Tokyo) 44, 949–955 (1991).

5. Omura, S., Ohno, H., Saheki, T., Yoshida, M. & Nakagawa, A. Elasnin a new human granulocyte elastase inhibitor produced by a strain of Streptomyces. Biochem. Biophys. Res. Commun. 83, 704–709 (1978).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-activity relationships of natural quinone vegfrecine analogs with potent activity against VEGFR-1 and -2 tyrosine kinases;The Journal of Antibiotics;2021-07-20

2. Erratum: Corrigendum: Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology;The Journal of Antibiotics;2018-01-29